Literature DB >> 27899032

Proteomic profiling of the spinal cord in ALS: decreased ATP5D levels suggest synaptic dysfunction in ALS pathogenesis.

Jooyeon Engelen-Lee1, Anna M Blokhuis2, Wim G M Spliet3, R Jeroen Pasterkamp2, Eleonora Aronica4, Jeroen A A Demmers5, Roel Broekhuizen3, Giovanni Nardo6, Niels Bovenschen3,7, Leonard H Van Den Berg8.   

Abstract

BACKGROUND: We aimed to gain new insights into the pathogenesis of sporadic ALS (sALS) through a comprehensive proteomic analysis.
METHODS: Protein profiles of the anterior and posterior horn in post-mortem spinal cord samples of 10 ALS patients and 10 controls were analysed using 2D-differential gel electrophoresis. The identified protein spots with statistically significant level changes and a spot ratio >2.0 were analysed by LC-MS/MS.
RESULTS: In the posterior horn only 3 proteins were differentially expressed. In the anterior horn, 16 proteins with increased levels and 2 proteins with decreased levels were identified in ALS compared to controls. The identified proteins were involved in mitochondrial metabolism, calcium homeostasis, protein metabolism, glutathione homeostasis, protein transport and snRNP assembly. The two proteins with decreased levels, ATP5D and calmodulin, were validated by Western blot and immunostaining. Immunohistochemical and immunofluorescent double staining of ATP5D and synaptophysin showed that the reduction of ATP5D was most pronounced at synapses.
CONCLUSIONS: We speculate that mitochondrial dysfunction in synaptic clefts could play an important role in sALS pathogenesis. A similar approach revealed decreased calmodulin expression mainly in the neuronal body and dendrites of ALS patients. These findings contribute to a deeper understanding of the disease process underlying ALS.

Entities:  

Keywords:  ATP5D; Amyotrophic lateral sclerosis; Two-Dimensional Differential Gel Electrophoresis (2D-DIGE); proteomics; spinal cord; synaptic mitochondrial defect

Mesh:

Substances:

Year:  2016        PMID: 27899032     DOI: 10.1080/21678421.2016.1245757

Source DB:  PubMed          Journal:  Amyotroph Lateral Scler Frontotemporal Degener        ISSN: 2167-8421            Impact factor:   4.092


  6 in total

1.  Pathogenic p62/SQSTM1 mutations impair energy metabolism through limitation of mitochondrial substrates.

Authors:  Fernando Bartolome; Noemi Esteras; Angeles Martin-Requero; Claire Boutoleau-Bretonniere; Martine Vercelletto; Audrey Gabelle; Isabelle Le Ber; Tadashi Honda; Albena T Dinkova-Kostova; John Hardy; Eva Carro; Andrey Y Abramov
Journal:  Sci Rep       Date:  2017-05-10       Impact factor: 4.379

2.  Multi-Study Proteomic and Bioinformatic Identification of Molecular Overlap between Amyotrophic Lateral Sclerosis (ALS) and Spinal Muscular Atrophy (SMA).

Authors:  Darija Šoltić; Melissa Bowerman; Joanne Stock; Hannah K Shorrock; Thomas H Gillingwater; Heidi R Fuller
Journal:  Brain Sci       Date:  2018-12-04

3.  Metabolic and Stress Response Changes Precede Disease Onset in the Spinal Cord of Mutant SOD1 ALS Mice.

Authors:  Gavin Pharaoh; Kavithalakshmi Sataranatarajan; Kaitlyn Street; Shauna Hill; Jake Gregston; Bumsoo Ahn; Caroline Kinter; Michael Kinter; Holly Van Remmen
Journal:  Front Neurosci       Date:  2019-05-31       Impact factor: 4.677

Review 4.  Biomarkers in Neurodegenerative Diseases: Proteomics Spotlight on ALS and Parkinson's Disease.

Authors:  Rekha Raghunathan; Kathleen Turajane; Li Chin Wong
Journal:  Int J Mol Sci       Date:  2022-08-18       Impact factor: 6.208

Review 5.  Functional Genomics of Axons and Synapses to Understand Neurodegenerative Diseases.

Authors:  Andres Di Paolo; Joaquin Garat; Guillermo Eastman; Joaquina Farias; Federico Dajas-Bailador; Pablo Smircich; José Roberto Sotelo-Silveira
Journal:  Front Cell Neurosci       Date:  2021-06-25       Impact factor: 5.505

Review 6.  Mechanistic Insights of Mitochondrial Dysfunction in Amyotrophic Lateral Sclerosis: An Update on a Lasting Relationship.

Authors:  Niccolò Candelise; Illari Salvatori; Silvia Scaricamazza; Valentina Nesci; Henri Zenuni; Alberto Ferri; Cristiana Valle
Journal:  Metabolites       Date:  2022-03-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.